Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603882'
s EV-to-FCF Range Over the Past 10 Years
Min: -160.93 Med: 43.52 Max: 1659.97
Current: 14.39
During the past 13 years, the highest EV-to-FCF of Guangzhou Kingmed Diagnostics Group Co was 1659.97. The lowest was -160.93. And the median was 43.52.
SHSE:603882's EV-to-FCF is ranked better than 69.7% of 99
companies
in the Medical Diagnostics & Research industry
Industry Median: 26.84
vs SHSE:603882: 14.39
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Guangzhou Kingmed Diagnostics Group Co's PE Ratio (TTM) for today is calculated as:
Guangzhou Kingmed Diagnostics Group Co's share price for today is ¥26.71.
Guangzhou Kingmed Diagnostics Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.220.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Guangzhou Kingmed Diagnostics Group Co EV-to-FCF Related Terms
Guangzhou Kingmed Diagnostics Group Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangzhou Kingmed Diagnostics Group Co EV-to-FCF Chart
Guangzhou Kingmed Diagnostics Group Co Annual Data
SHSE:603882 vs TMO, DHR, IDXX: EV-to-FCF Comparison
For the Diagnostics & Research subindustry, Guangzhou Kingmed Diagnostics Group Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangzhou Kingmed Diagnostics Group Co EV-to-FCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Guangzhou Kingmed Diagnostics Group Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Guangzhou Kingmed Diagnostics Group Co's EV-to-FCF falls into.
Guangzhou Kingmed Diagnostics Group Co's current Enterprise Value is ¥11,008 Mil.
Guangzhou Kingmed Diagnostics Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥766 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) has a EV-to-FCF of 14.38 as of Jul. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Guangzhou Kingmed Diagnostics Group Co and its competitors. This is 67% below median its historical median of 43.52. According to the industry distribution chart, Guangzhou Kingmed Diagnostics Group Co ranks #30 out of 99 companies in the Medical Diagnostics & Research industry, placing it in the top 30.3%.
Is Guangzhou Kingmed Diagnostics Group Co's EV-to-FCF too high?
Guangzhou Kingmed Diagnostics Group Co's current EV-to-FCF of 14.38 is 67% below median its 10-year median of 43.52. The Medical Diagnostics & Research industry median EV-to-FCF is 26.84. Guangzhou Kingmed Diagnostics Group Co's value of 14.38 is 46.4% below this industry median. Based on the distribution chart, Guangzhou Kingmed Diagnostics Group Co ranks #30 out of 99 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Guangzhou Kingmed Diagnostics Group Co has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Kingmed Diagnostics Group Co's EV-to-FCF compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Guangzhou Kingmed Diagnostics Group Co ranks #30 out of 99 companies for EV-to-FCF. This puts Guangzhou Kingmed Diagnostics Group Co in the upper half of its industry. The industry median EV-to-FCF is 26.84. Guangzhou Kingmed Diagnostics Group Co's value of 14.38 is 46.4% below this benchmark. While the company's 10-year median is 43.52 vs. the industry median of 26.84, Guangzhou Kingmed Diagnostics Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Diagnostics & Research company?
The median EV-to-FCF among Medical Diagnostics & Research companies is 26.84, based on 99 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangzhou Kingmed Diagnostics Group Co's current EV-to-FCF of 14.38 is 46.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Guangzhou Kingmed Diagnostics Group Co and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-FCF is 26.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangzhou Kingmed Diagnostics Group Co's current EV-to-FCF is 14.38, which is 67% below median its own 10-year median of 43.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Kingmed Diagnostics Group Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) is currently considered Fairly Valued. The stock's GF Value™ is ¥27.91, compared to a current price of ¥26.71 — trading 4.3% below its estimated fair value. The current EV-to-FCF is 14.38, which is 67% below median its 10-year median of 43.52 and 46.4% below the Medical Diagnostics & Research industry median of 26.84. Guangzhou Kingmed Diagnostics Group Co's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Guangzhou Kingmed Diagnostics Group Co (SHSE:603882), the current EV-to-FCF is 14.38 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) Overvalued in 2026?
Based on GuruFocus' analysis, Guangzhou Kingmed Diagnostics Group Co stock appears to be undervalued.
The current stock price of ¥26.71 is trading 4.3% below its estimated GF Value™ of ¥27.91.
GuruFocus considers Guangzhou Kingmed Diagnostics Group Co to be Fairly Valued.
Key valuation signals for SHSE:603882:
EV-to-FCF: 14.38 (67% below median its 10-year median of 43.52)
GF Value™: ¥27.91 vs. price of ¥26.71 (4.3% below fair value)
Industry Position: 46.4% below the Medical Diagnostics & Research median (#30 of 99)
No single metric tells the full story. See the SHSE:603882 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangzhou Kingmed Diagnostics Group Co Business Description
Founded in 1994, KingMed is the largest independent clinical laboratory in China. It was listed on the Shanghai Stock Exchange in 2017. As of 2024, KingMed has 50 centralized labs and provides over 4000 test items. Over 90% of its total revenue comes from clinical diagnostics. Furthermore, KingMed has been actively investing in its cold chain logistics. Its service network covers the most intensely populated areas in China.
74GF Score
Get the complete analysis for SHSE:603882
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603882 has been successfully added to your 
